An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2004)
The DOI matches its Crossref record.
Abstract
A statistical survey of 3932 nationwide hemodialysis (hereafter, dialysis) facilities was carried out at the end of 2004, and 3882 facilities (98.73%) responded. The population undergoing dialysis at the end of 2004 was 248 166, an increase of 10 456 patients (4.4%) from that at the end of 2003. The number of dialysis patients per million people was 1943.5. The crude death rate of dialysis patients from the end of 2003 to the end of 2004 was 9.4%. The mean age of patients who underwent dialysis in 2004 was 65.8 years, and that of the total dialysis population was 63.3 years. The percentage distribution of patients who underwent dialysis according to a newly underlying disease showed that 41.3% of patients had diabetic nephropathy and 28.1% had chronic glomerulonephritis. The frequency of calcium carbonate use for dialysis patients was 75.1% and that of sevelamer hydrochloride use was 26.2%. The frequency of sevelamer hydrochloride use does not necessarily have a strong correlation with the dose of calcium carbonate. Patients who received high doses of sevelamer hydrochloride tended to have a low concentration of arterial blood HCO 3–. Approximately 15% of dialysis patients used an intravenous vitamin D preparation, generally maxacalcitol. The longer the patients had been on dialysis, the higher the frequency of use of an intravenous vitamin D preparation. When the concentration of serum intact parathyroid hormone (PTH) was more than 200 pg/mL, the frequency of use of an orally administered vitamin D preparation decreased; but that of intravenous vitamin D preparation increased. The percentage of dialysis patients who received percutaneous ethanol injection therapy (PEIT) was 1.4%. The percentage was more than 50% in the patients who had been on dialysis for more than 10 years. The percentage of patients who received PEIT again was 35.0%. The percentage of patients who had been on hemodialysis for more than 10 years and received PEIT again was more than 50%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Astaxanthin protects mesangial cells from hyperglycemia‐induced oxidative signaling
Manabe, E., Handa, O., Naito, Y., Mizushima, K., Akagiri, S., Adachi, S., Takagi, T., Kokura, S., Maoka, T., & Yoshikawa, T. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21583 · Cited by 132
New strategies and perspectives on managing IgA nephropathy
Selvaskandan, H., Cheung, C. K., Muto, M., & Barratt, J. (2019) · Clinical and Experimental Nephrology · doi:10.1007/s10157-019-01700-1 · Cited by 83
Takenaka, T., Hoshi, H., Kato, N., Kobayashi, K., Takane, H., Shoda, J., & Suzuki, H. (2008) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e584 · Cited by 45
Metadata
- Authors
- Nakai, S., Wada, A., Kitaoka, T., Shinzato, T., Nagura, Y., Kikuchi, K., Masakane, I., Shinoda, T., Yamazaki, C., Sakai, R., Marubayashi, S., Morita, O., Iseki, K., Usami, T., Kimata, N., Suzuki, K., Tabei, K., Fushimi, K., Miwa, N., Yauchi, M., Wakai, K., & Akiba, T.
- Venue
- Therapeutic Apheresis and Dialysis
- Publisher
- Wiley
- Published
- 2006-12
- Volume
- 10
- Issue
- 6
- Pages
- 476-497
- ISSN
- 1091-6660 (ISSN-L)
- 1744-9979
- 1744-9987
- OpenAlex
- W2073591401
- Cited by
- 65
- References
- 0
- FWCI
- 7.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2004). https://app.cochat.ai/papers/10.1111/j.1744-9987.2006.00440.x
- The paper
- Nakai, S., Wada, A., Kitaoka, T., Shinzato, T., Nagura, Y., Kikuchi, K., Masakane, I., Shinoda, T., Yamazaki, C., Sakai, R., Marubayashi, S., Morita, O., Iseki, K., Usami, T., Kimata, N., Suzuki, K., Tabei, K., Fushimi, K., Miwa, N., . . . Akiba, T. (2006). An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2004). Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/j.1744-9987.2006.00440.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.